ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection

NCT06342921 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

749

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Effect of Drug

Interventions

DRUG: 15 mg ADC189
DRUG: 45 mg ADC189
DRUG: Placebo

Sponsor

Jiaxing AnDiCon Biotech Co.,Ltd